Emblem (EMMBF) Stock Price, News & Analysis

Company Overview

Emblem Corp. was a Canadian cannabis company focused on the cultivation, production and distribution of medical cannabis. The company developed cannabis products including dried cannabis, cannabis oils and capsules for patients and consumers in regulated markets.

Emblem operated in Canada and pursued opportunities in both the medical cannabis and adult-use recreational cannabis sectors. Its business included cannabis cultivation, product development and brand-building, with products distributed through authorized channels subject to Canadian regulations.

In 2020, Emblem entered into an arrangement to be acquired by Aleafia Health Inc., combining its operations with Aleafia’s cannabis business. As a result, Emblem may no longer operate as an independent publicly traded company under its former identity.

Key Stats

• Today's Range: $1.36 to $1.45
• 50-Day Range: $1.40 to $1.40
• 52-Week Range: $0.60 to $1.63
• Volume: 156,200 shs
• Average Volume: 280,719 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:EMMBF
• CIK: N/A
• Web: emblemcorp.com
• Phone: (416) 962-3300
• Fax: N/A
• Employees: 74
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A